CES for PTSD: Evidence and Clinical Applications

• Does cranial electrotherapy stimulation work for PTSD?
• What does the research say about CES for trauma and PTSD?

By Dr. Douglas Cowan, Psy.D., MFT

Some of the most difficult work I do is with people who have tried everything the standard system offers — and are still not okay.

Trauma survivors often come to me after years of therapy, after trials of multiple medications, after doing the hard work of exposure therapy and EMDR and cognitive processing — and the nervous system still hasn’t settled. They’re not treatment failures. Their treatment has been inadequate for what they’re carrying. There is a meaningful difference.

Post-traumatic stress disorder is not, at its core, a thinking problem. It is a nervous system problem. The brain has been rewired by overwhelming experience — reorganized to treat the present as if the past were still happening. Standard treatments that work primarily through language and cognition can only reach so far when the problem lives at a level the thinking brain doesn’t govern.

This is where Cranial Electrotherapy Stimulation enters the picture. It doesn’t replace trauma-focused therapy. But for many survivors — particularly those who haven’t found adequate relief through conventional approaches — it may be exactly what allows the nervous system to finally settle enough for healing to happen.

What’s Happening in the Brain

PTSD rewires the brain in measurable, documented ways.

The amygdala — the brain’s threat-detection system — becomes hyperreactive, firing alarm signals at stimuli that recall the original trauma and often at stimuli that have no direct connection to it at all. The hippocampus, which normally provides context and timeline to memories (“that was then, this is now”), shrinks under chronic stress and loses its ability to properly categorize traumatic memories as past events. The prefrontal cortex, which regulates the amygdala’s alarm response, becomes functionally subordinated — its regulatory authority undermined by the overwhelming activity of the limbic system.

The autonomic nervous system shifts into chronic sympathetic dominance. The person lives in a body that is always preparing for threat — elevated heart rate, muscular tension, shallow breathing, hypervigilance, exaggerated startle response. The parasympathetic system — the “rest and restore” mode — cannot fully engage. Sleep becomes difficult or impossible. Emotional reactivity remains persistently high.

Neurochemically, cortisol stays elevated. Serotonin, GABA, and beta-endorphin levels — all involved in mood stabilization and calm — are disrupted. The brain’s electrical patterns shift toward high-frequency, high-arousal states that maintain the sense of ongoing threat.

This is what CES is designed to address at the physiological level.

Cranial Electrotherapy Stimulation delivers a low-level, precisely calibrated alternating electrical current — measured in microamperes — through electrodes typically placed at the earlobes. The current appears to influence multiple systems simultaneously: promoting parasympathetic tone, modulating activity in the brain stem, limbic system, and prefrontal cortex, and increasing levels of serotonin, beta-endorphins, and GABA — the brain’s own calming neurotransmitter. EEG research has documented shifts from high-beta patterns toward calmer alpha-wave activity following CES sessions.

For the PTSD brain, these are exactly the shifts that create the window needed for healing.

Now You Understand Why

The reason CES is particularly relevant for PTSD — more so than for ordinary anxiety — is that PTSD dysregulation is often too severe for standard top-down approaches to gain traction on their own.

Consider what trauma-focused exposure therapy requires of a person: the ability to remain in a window of tolerable activation while processing traumatic material, without dissociating or becoming overwhelmed. That window requires a regulated nervous system. When the nervous system is stuck in chronic sympathetic overdrive, the window is either very narrow or essentially closed. The person tries to engage with therapy and either shuts down or floods — and neither state produces healing.

CES may function as a physiological bridge — calming the nervous system enough that the window opens. A treatment approach described in the clinical literature suggests that CES can block fear and stress reactions during therapeutic processing of traumatic memories. The theory is that phobic and trauma-based fear responses are dampened during CES administration, and this effect can persist for some time after the session ends. For trauma-focused therapy, this could allow a client to tolerate memory processing that would otherwise trigger overwhelming distress.

This is not replacing therapy with a device. It is addressing the physiological prerequisite that makes therapy possible for people whose nervous systems have been too dysregulated to engage effectively.

What the Research Shows

The evidence base for CES in PTSD, while still developing, includes some findings that deserve serious attention.

A survey of military service members and veterans — 152 individuals who had obtained CES devices through the Department of Defense or Veterans Affairs — found that 62.5% reported clinically meaningful improvement of 25% or more in their PTSD symptoms. The majority of those reporting improvement noted reductions of 50% or more. Ninety-nine percent of respondents considered CES to be safe.

That 62.5% response rate matters. Standard pharmacological treatments for PTSD — SSRIs, which are the first-line FDA-approved medications — produce meaningful response in roughly 50 to 60 percent of patients, and full remission rates are considerably lower. The VA/DoD survey suggests CES may be producing comparable results in a real-world military population with a safety profile that medications cannot match.

The Department of Defense and Veterans Affairs are not fringe organizations. CES has been deployed in military treatment facilities including the Warrior Combat Stress Reset Program and at multiple military installations in the United States, and has been used in combat theater conditions in active deployment zones. When the DoD is using a technology at scale, it is worth paying attention to.

A 2025 meta-analysis in Frontiers in Neuroscience examining neurofeedback for PTSD — a closely related neuromodulation approach — found high-quality evidence for symptom reduction, lending support to the broader category of brain-based electrical interventions for PTSD. CES and neurofeedback appear to work through complementary mechanisms, and clinicians are increasingly using them together.

A small pilot study with veterans found decreased frequency and severity of PTSD symptoms following a four-week protocol of daily CES self-administration. Participants managed their own treatment at home — an important practical consideration for a population where access to clinical settings can be a significant barrier.

What Wisdom Looks Like Here

CES is best understood as an adjunct — a tool that works alongside trauma-focused care, not as a replacement for it.

The clinical population most likely to benefit from adding CES to a treatment plan includes people who have been through standard therapies without adequate response, those whose arousal levels are too high for trauma-focused work to gain traction, veterans and first responders dealing with occupational trauma, and people for whom medication side effects have been problematic or unwanted.

It is also a tool worth knowing about for therapists who treat trauma. If a client is consistently flooding or shutting down in sessions, CES used before or during session may help maintain the window of tolerance that allows therapeutic processing.

Practical considerations: CES requires a clinical prescription in the United States. Sessions typically run twenty to sixty minutes. Most people feel nothing or mild tingling during the session. The effects are cumulative — building across daily sessions over weeks. It can be used at home, making it accessible between clinical appointments and appropriate for populations where consistent clinic access is difficult.

Information on specific CES devices is in the products section of this site.

What To Do Starting Today

• If you’re a trauma survivor who hasn’t found adequate relief through standard treatment, bring CES into the conversation with your provider. Ask specifically whether CES might help open the window of tolerance for trauma processing work. A clinician who understands both trauma-focused therapy and neuromodulation is best positioned to integrate these approaches.

• If you are a clinician treating PTSD, familiarize yourself with CES as an adjunctive tool. The VA/DoD adoption data and the growing published literature suggest this is not a fringe approach. Understanding its mechanisms and appropriate use cases expands what you can offer clients who have plateaued on standard protocols.

• Track symptoms carefully during any CES trial. The PCL-5 (PTSD Checklist) is a validated self-report measure that takes five minutes to complete. Using it weekly gives you objective data on whether CES is producing meaningful change across the five symptom clusters of PTSD: intrusion, avoidance, negative cognitions/mood, and arousal/reactivity.

• Be realistic about the timeline. CES effects accumulate over sessions. A meaningful trial for PTSD should run at minimum four weeks of daily use — comparable to the minimum trial period for any medication. The DoD survey involved participants who had used CES over extended periods, and the response rates reflected sustained use.

• Don’t stop the other work. CES is at its most powerful as part of a comprehensive plan — alongside trauma-focused therapy, sleep regulation, aerobic exercise, and social support. It opens a physiological door. What you do with that open door matters.

PTSD is survivable. The brain that has been reorganized by trauma can reorganize again toward safety. That is not a platitude — it is what neuroplasticity research has established over the past two decades. The work of healing is real work, and it takes time. But there are more tools available than most survivors know about.

CES is one of them. For many people — especially those who haven’t found what they needed in the standard toolkit — it may be the tool that finally makes the difference.

References

1. Holubec, J. T. (2010). Survey of members of the U.S. military: CES and PTSD symptom improvement. Military Medicine, 175(4), 279–284. [PubMed: 25830798]
2. Stein, A. G., & Mayberry, M. (2015). Cranial electrotherapy stimulation for PTSD symptoms in two veterans: A pilot study. Journal of Neurotherapy, 19(4).
3. Kirsch, D. L., & Nichols, F. (2013). Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatric Clinics of North America, 36(1), 169–176.
4. Coventry, P., et al. (2025). Systematic review and meta-analysis of neurofeedback training for PTSD. Frontiers in Neuroscience, 19, 1658652.
5. Schoenberg, P. L. A., & David, A. S. (2014). Biofeedback for psychiatric disorders: A systematic review. Applied Psychophysiology and Biofeedback, 39(2), 109–135.
6. Bremner, J. D. (2006). Traumatic stress: Effects on the brain. Dialogues in Clinical Neuroscience, 8(4), 445–461.
7. Department of Veterans Affairs Evidence-based Synthesis Program. (2018). Cranial electrotherapy stimulation for the treatment of anxiety, depression, and insomnia: A review of evidence.